InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,722.85
(
-0.18%
)
US TECH 100
19,435.60
(
0.11%
)
Dow Jones
41,950.47
(
-0.61%
)
Brent Oil
73.03
(
-2.06%
)
Bitcoin
63,331.54
(
-1.46%
)
Post# of 253221
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

imnot6

Send PM Follow Ignore
Followers 3
Posts 857
Boards Moderated 0
Alias Born 11/28/2005

imnot6

Member Level

Re: jbog post# 199368

Friday, 02/05/2016 2:31:32 PM

Friday, February 05, 2016 2:31:32 PM

Post# of 253221
Related note: I've been seeing pharmacies approving Teva's Granix as a replacement agent for Neupogen with no mention of any exceptions, which puzzles me, because I though Granix in the US was only approved for chemo-induced neutropenia. Do pharmacy and therapeutic committees get to make "judgement calls" like that?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up